Caricamento...
Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma
Pancreatic adenocarcinoma is still widely considered as a deadly disease even though there are substantial therapeutic developments in the past decade. Using combinational chemotherapy regimens, represented by gemcitabine plus nab-paclitaxel and FOLFIRINOX, was able to improve overall survival in pa...
Salvato in:
| Pubblicato in: | J Gastrointest Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5506276/ https://ncbi.nlm.nih.gov/pubmed/28736631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.10.02 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|